Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

173.53
Delayed Data
As of 1:02pm ET
 -1.30 / -0.74%
Today’s Change
169.61
Today|||52-Week Range
256.80
-17.37%
Year-to-Date

Today’s Trading

Previous close174.83
Today’s open175.00
Day’s range173.11 - 175.43
Volume797,698
Average volume (3 months)3,117,647
Market cap$58.1B
Dividend yield1.61%
Data as of 1:02pm ET, 11/24/2017

Growth & Valuation

Earnings growth (last year)+281.42%
Earnings growth (this year)+20.26%
Earnings growth (next 5 years)+9.40%
Revenue growth (last year)-3.32%
P/E ratioNM
Price/Sales5.55
Price/Book0.82

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca+0.01+0.03%
ABTAbbott Laboratories+0.33+0.59%
LLYEli Lilly and Co+0.35+0.42%
NVONovo Nordisk+0.40+0.77%
Data as of 1:02pm ET, 11/24/2017

Financials

Next reporting dateFebruary 21, 2018
EPS forecast (this quarter)$4.74
Annual revenue (last year)$14.6B
Annual profit (last year)$15.0B
Net profit margin-6.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts